A simple method for quantitation of insulin sensitivity and insulin release from an intravenous glucose tolerance test. 1992

P Galvin, and G Ward, and J Walters, and R Pestell, and M Koschmann, and A Vaag, and I Martin, and J D Best, and F Alford
Endocrine Unit, St. Vincent's Hospital, Fitzroy, Victoria, Australia.

Both insulin secretion and insulin sensitivity are important in the development of diabetes but current methods used for their measurements are complex and cannot be used for epidemiological surveys. This study describes a simplified approach for the estimation of first phase insulin release and insulin sensitivity from a standard 40-min intravenous glucose tolerance test (IVGTT), and compares these parameter estimations with the sophisticated minimal model analysis of a frequently sampled 3-h IVGTT and the euglycaemic clamp technique. For the simplified IVGTT, first phase insulin release was measured as the insulin area above basal post glucose load unit-1 incremental change (i.e. peak rise) in plasma glucose over 0-10 min, and insulin sensitivity as a rate of glucose disappearance (Kg) unit-1 insulin increase above basal from 0-40 min post-glucose load in 18 subjects who were studied twice, either basally or in a perturbed pathophysiological state (i.e. pre- and post-ultramarathon race, n = 5; pre- and post-20 h pulsatile hyperinsulinaemia, n = 8; pre- and post-thyrotoxic state, n = 5). A further 12 subjects were compared by IVGTT, and glucose clamp. In addition, seven dogs were studied three times by IVGTT during normal saline infusion and after short-term (1/2 hour) or long-term (72 hour) adrenaline infusions. First phase insulin release and insulin sensitivity estimated from the simplified IVGTT as calculated by the two methods correlated closely (rs = 0.89 and rs = 0.87, respectively), although less precisely in markedly insulin-resistant subjects and the slopes and y intercepts of the linear regression lines were similar in the basal and perturbed states.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007332 Insulin Infusion Systems Portable or implantable devices for infusion of insulin. Includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor. Pancreas, Artificial Endocrine,Programmable Implantable Insulin Pump,beta Cell, Artificial,Implantable Programmable Insulin Pump,Insulin Pump, Programmable Implantable,Pump, Programmable Implantable Insulin,Artificial Endocrine Pancreas,Artificial beta Cell,Artificial beta Cells,Cell, Artificial beta,Cells, Artificial beta,Endocrine Pancreas, Artificial,Infusion System, Insulin,Infusion Systems, Insulin,Insulin Infusion System,System, Insulin Infusion,Systems, Insulin Infusion,beta Cells, Artificial
D008297 Male Males
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D012420 Running An activity in which the body is propelled by moving the legs rapidly. Running is performed at a moderate to rapid pace and should be differentiated from JOGGING, which is performed at a much slower pace. Runnings

Related Publications

P Galvin, and G Ward, and J Walters, and R Pestell, and M Koschmann, and A Vaag, and I Martin, and J D Best, and F Alford
May 2011, Theoretical biology & medical modelling,
P Galvin, and G Ward, and J Walters, and R Pestell, and M Koschmann, and A Vaag, and I Martin, and J D Best, and F Alford
March 2001, Diabetes care,
P Galvin, and G Ward, and J Walters, and R Pestell, and M Koschmann, and A Vaag, and I Martin, and J D Best, and F Alford
October 1990, Diabetes research and clinical practice,
P Galvin, and G Ward, and J Walters, and R Pestell, and M Koschmann, and A Vaag, and I Martin, and J D Best, and F Alford
February 2024, Scandinavian journal of medicine & science in sports,
P Galvin, and G Ward, and J Walters, and R Pestell, and M Koschmann, and A Vaag, and I Martin, and J D Best, and F Alford
May 1979, Clinical chemistry,
P Galvin, and G Ward, and J Walters, and R Pestell, and M Koschmann, and A Vaag, and I Martin, and J D Best, and F Alford
March 2000, Diabetes care,
P Galvin, and G Ward, and J Walters, and R Pestell, and M Koschmann, and A Vaag, and I Martin, and J D Best, and F Alford
May 2009, American journal of physiology. Regulatory, integrative and comparative physiology,
P Galvin, and G Ward, and J Walters, and R Pestell, and M Koschmann, and A Vaag, and I Martin, and J D Best, and F Alford
March 1991, The Journal of clinical endocrinology and metabolism,
P Galvin, and G Ward, and J Walters, and R Pestell, and M Koschmann, and A Vaag, and I Martin, and J D Best, and F Alford
January 1994, Diabete & metabolisme,
P Galvin, and G Ward, and J Walters, and R Pestell, and M Koschmann, and A Vaag, and I Martin, and J D Best, and F Alford
August 1996, Journal of the Formosan Medical Association = Taiwan yi zhi,
Copied contents to your clipboard!